DIFFERENTIAL ACTIVITIES OF 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES AGAINST DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANT STRAINS

被引：31

作者：

BALZARINI, J ^{[1
]}

BABA, M ^{[1
]}

DECLERCQ, E ^{[1
]}

机构：

[1] KAGOSHIMA UNIV,FAC MED,CTR CHRON VIRAL DIS,DIV HUMAN RETROVIRUSES,KAGOSHIMA 890,JAPAN

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1995年 / 39卷 / 04期

关键词：

D O I：

10.1128/AAC.39.4.998

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A series of 23 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives that were highly potent inhibitors of wild-type human immunodeficiency virus type 1 strain containing the replacement of leucine by isoleucine at position 100 (100-Leu-->Ile), 103-Lys-->Asn, 106-Val-->Ala, 138-Glu-->Lys, 181-Tyr-->Cys, 181-Tyr-->Ile, or 188-Tyr-->His in their reverse transcriptase (RT). A different structure-antiviral activity relationship was found, depending on the nature of the mutated amino acid in the HIV-1 RT. The results show that 5-ethyl-1-ethoxymethyl-6-(3,5-dimethylbenzyl)uracil, 5-ethyl-1-ethoxymethyl-6-(3,5-dimethylphenylthio)uracil, and 5-ethyl-1-ethoxymethyl-6-(3,5-dimethylphenylthio)-2-thiouracil remain active against the majority of viruses containing single mutations which confer resistance to nonnucleoside RT inhibitors.

引用

页码：998 / 1002

页数：5

共 28 条

[1]

BABA M, 1991, MOL PHARMACOL, V39, P805

[2] POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY 5-ETHYL-6-PHENYLTHIOURACIL DERIVATIVES THROUGH THEIR INTERACTION WITH THE HIV-1 REVERSE-TRANSCRIPTASE [J].

BABA, M ;

DECLERCQ, E ;

TANAKA, H ;

UBASAWA, M ;

TAKASHIMA, H ;

SEKIYA, K ;

NITTA, I ;

UMEZU, K ;

NAKASHIMA, H ;

MORI, S ;

SHIGETA, S ;

WALKER, RT ;

MIYASAKA, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2356-2360

[3] HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].

BABA, M ;

TANAKA, H ;

DECLERCQ, E ;

PAUWELS, R ;

BALZARINI, J ;

SCHOLS, D ;

NAKASHIMA, H ;

PERNO, CF ;

WALKER, RT ;

MIYASAKA, T .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381

[4] HUMAN-IMMUNODEFICIENCY-VIRUS-1 (HIV-1)-SPECIFIC REVERSE-TRANSCRIPTASE (RT) INHIBITORS MAY SUPPRESS THE REPLICATION OF SPECIFIC DRUG-RESISTANT (E138K)RT HIV-1 MUTANTS OR SELECT FOR HIGHLY RESISTANT (Y181C-]C181I)RT HIV-1 MUTANTS [J].

BALZARINI, J ;

KARLSSON, A ;

SARDANA, VV ;

EMINI, EA ;

CAMARASA, MJ ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6599-6603

[5] TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED CELLS WITH COMBINATIONS OF HIV-1-SPECIFIC INHIBITORS RESULTS IN A DIFFERENT RESISTANCE PATTERN THAN DOES TREATMENT WITH SINGLE-DRUG THERAPY [J].

BALZARINI, J ;

KARLSSON, A ;

PEREZPEREZ, MJ ;

CAMARASA, MJ ;

TARPLEY, WG ;

DECLERCQ, E .

JOURNAL OF VIROLOGY, 1993, 67 (09) :5353-5359

[6]

BALZARINI J, 1993, MOL PHARMACOL, V43, P109

[7] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS SELECTED FOR RESISTANCE AGAINST THE HIV-1-SPECIFIC [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE)]-BETA-D-PENTOFURANOSYL (TSAO) NUCLEOSIDE ANALOGS RETAIN SENSITIVITY TO HIV-1-SPECIFIC NONNUCLEOSIDE INHIBITORS [J].

BALZARINI, J ;

KARLSSON, A ;

VANDAMME, AM ;

PEREZPEREZ, MJ ;

ZHANG, H ;

VRANG, L ;

OBERG, B ;

BACKBRO, K ;

UNGE, T ;

SANFELIX, A ;

VELAZQUEZ, S ;

CAMARASA, MJ ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :6952-6956

[8] HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS SHOW DIFFERENTIAL ACTIVITY AGAINST HIV-1 MUTANT STRAINS CONTAINING DIFFERENT AMINO-ACID SUBSTITUTIONS IN THE REVERSE-TRANSCRIPTASE [J].

BALZARINI, J ;

KARLSSON, A ;

PEREZPEREZ, MJ ;

VRANG, L ;

WALBERS, J ;

ZHANG, H ;

OBERG, B ;

VANDAMME, AM ;

CAMARASA, MJ ;

DECLERCQ, E .

VIROLOGY, 1993, 192 (01) :246-253

[9]

BALZARINI J, 1993, MOL PHARMACOL, V44, P694

[10]

Balzarini Jan, 1993, Drugs of the Future, V18, P1043

← 1 2 3 →